Posted on October 27th, 2014
Mr. Commissiong was appointed President and CEO of Amarantus BioScience in October 2011.
Amarantus BioScience Holdings, Inc. is a biotechnology company developing treatments and diagnostics for diseases associated with neurodegeneration and protein misfolding-related apoptosis. The Company has licensed Eltoprazine (“Eltoprazine”), a phase 2b ready indication for Parkinson’s Levodopa induced dyskinesia and Adult ADHD. The Company has an exclusive worldwide license to the Lymphocyte Proliferation test (“LymPro Test®”) for Alzheimer’s disease and owns the intellectual property rights to a therapeutic protein known as Mesencephalic-Astrocyte-derived Neurotrophic Factor (“MANF”) and is developing MANF-based products as treatments for brain disorders. Amarantus is a Founding Member of the Coalition for Concussion Treatment (#C4CT), a movement initiated in collaboration with Brewer Sports International seeking to raise awareness of new treatments in development for concussions and nervous-system disorders. The Company also owns intellectual property for the diagnosis of Parkinson’s disease (“NuroPro”) and the discovery of neurotrophic factors (“PhenoGuard”).
The last several weeks have been a particularly exciting time for the team at Amarantus. Months of effort are beginning ...Read More »
Posted on October 23rd, 2014
2014 has been a year of very significant change for MabVax Therapeutics. We became a publicly listed company, received a...Read More »
Posted on October 22nd, 2014
As a youth football coach for the past several years, one thing I have learned is that in order to succeed, you need to ...Read More »
Posted on October 16th, 2014
We often hear that an educated patient is an empowered patient, and this summer I heard an inspiring story about how one...Read More »
Posted on October 15th, 2014
Making money from war is not a recent phenomenon. In a 1935 publication, two time Medal of Honor awardee, Major Genera...Read More »
Reveal Insights About Your Company and Industry to Shareholders.
The Chairman's Blog is an exclusive, online media publication where publicly and privately held firms alike share insights about their companies and industries. The Chairman's Blog enables upper tier management to discuss issues that are of importance to their stakeholders, shareholders, and interested parties in an informal environment. Learn More »